Literature DB >> 27743994

Role of HIF-1α in the hypoxia inducible expression of the thiamine transporter, SLC19A3.

Kristy Zera1, Rebecca Sweet1, Jason Zastre2.   

Abstract

Ensuring continuous intracellular supply of thiamine is essential to maintain metabolism. Cellular homeostasis requires the function of the membrane bound thiamine transporters THTR1 and THTR2. In the absence of increased dietary intake of thiamine, varying intracellular levels to meet metabolic demands during pathophysiological stressors, such as hypoxia, requires adaptive regulatory mechanisms to increase thiamine transport capacity. Previous work has established the up-regulation of SLC19A3 (THTR2) gene expression and activity during hypoxic stress through the activity of the hypoxia inducible transcription factor 1 alpha (HIF-1α). However, it is unknown whether HIF-1α acts directly or indirectly to trans-activate expression of SLC19A3. This work utilized the breast cancer cell line BT-474 treated with 1% O2 or a hypoxia chemical mimetic deferoxamine to determine the minimal promoter region of SLC19A3 responsible for hypoxia responsiveness. In silico sequence analysis determined two contiguous hypoxia responsive elements in close proximity to the transcriptional start site of the SLC19A3 gene. Using a HIF-1α transcriptional factor ELISA assay, HIF-1α was capable of binding to a dsDNA construct of the SLC19A3 minimal promoter. Chromatin immunoprecipitation assay established that SP1 was bound to the SLC19A3 minimal promoter region under normoxic conditions. However, HIF-1α binding to the minimal promoter region occurred during hypoxic treatments, while no SP1 binding was observed under these conditions. This work demonstrates the direct binding and activation of SLC19A3 expression by HIF-1α during hypoxic stress, suggesting an important adaptive regulatory role for HIF-1α in maintaining thiamine homeostasis.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; HIF-1α; Hypoxia; Thiamine; Transporter

Mesh:

Substances:

Year:  2016        PMID: 27743994      PMCID: PMC5097002          DOI: 10.1016/j.gene.2016.10.013

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  54 in total

1.  HIF1-α-mediated gene expression induced by vitamin B1 deficiency.

Authors:  Rebecca L Sweet; Jason A Zastre
Journal:  Int J Vitam Nutr Res       Date:  2013       Impact factor: 1.784

Review 2.  Effects of thiamine deficiency on brain metabolism: implications for the pathogenesis of the Wernicke-Korsakoff syndrome.

Authors:  R F Butterworth
Journal:  Alcohol Alcohol       Date:  1989       Impact factor: 2.826

3.  Thiamine attenuates hypoxia-induced cell death in cultured neonatal rat cardiomyocytes.

Authors:  Bo Hee Shin; Seung Hyuk Choi; Eun Young Cho; Min-Jeong Shin; Ki-Chul Hwang; Hong Keun Cho; Ji Hyung Chung; Yangsoo Jang
Journal:  Mol Cells       Date:  2004-10-31       Impact factor: 5.034

4.  Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1.

Authors:  Huasheng Lu; Clifton L Dalgard; Ahmed Mohyeldin; Thomas McFate; A Sasha Tait; Ajay Verma
Journal:  J Biol Chem       Date:  2005-10-13       Impact factor: 5.157

5.  Neuronal deficiency of HIF prolyl 4-hydroxylase 2 in mice improves ischemic stroke recovery in an HIF dependent manner.

Authors:  Lexiao Li; Pamela Saliba; Stefan Reischl; Hugo H Marti; Reiner Kunze
Journal:  Neurobiol Dis       Date:  2016-03-19       Impact factor: 5.996

6.  In vitro and in vivo characterization of the minimal promoter region of the human thiamin transporter SLC19A2.

Authors:  Jack C Reidling; Hamid M Said
Journal:  Am J Physiol Cell Physiol       Date:  2003-09       Impact factor: 4.249

7.  Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1.

Authors:  G L Semenza; B H Jiang; S W Leung; R Passantino; J P Concordet; P Maire; A Giallongo
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

8.  High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease.

Authors:  P J Thornalley; R Babaei-Jadidi; H Al Ali; N Rabbani; A Antonysunil; J Larkin; A Ahmed; G Rayman; C W Bodmer
Journal:  Diabetologia       Date:  2007-08-04       Impact factor: 10.122

Review 9.  Transcriptional regulation by hypoxia inducible factors.

Authors:  Veronica L Dengler; Matthew Galbraith; Joaquín M Espinosa
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-10-07       Impact factor: 8.250

10.  Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted.

Authors:  S Langbein; M Zerilli; A Zur Hausen; W Staiger; K Rensch-Boschert; N Lukan; J Popa; M P Ternullo; A Steidler; C Weiss; R Grobholz; F Willeke; P Alken; G Stassi; P Schubert; J F Coy
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

View more
  5 in total

Review 1.  A guide to plasma membrane solute carrier proteins.

Authors:  Mattia D Pizzagalli; Ariel Bensimon; Giulio Superti-Furga
Journal:  FEBS J       Date:  2020-09-18       Impact factor: 5.542

2.  Thiamine deficiency activates hypoxia inducible factor-1α to facilitate pro-apoptotic responses in mouse primary astrocytes.

Authors:  Kristy Zera; Jason Zastre
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

Review 3.  SP and KLF Transcription Factors in Cancer Metabolism.

Authors:  Emilia J Orzechowska-Licari; Joseph F LaComb; Aisharja Mojumdar; Agnieszka B Bialkowska
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

4.  The adaptive regulation of thiamine pyrophosphokinase-1 facilitates malignant growth during supplemental thiamine conditions.

Authors:  Hunter C Jonus; Bradley S Hanberry; Shivani Khatu; Jaeah Kim; Hendrik Luesch; Long H Dang; Michael G Bartlett; Jason A Zastre
Journal:  Oncotarget       Date:  2018-10-23

5.  Fursultiamine Alleviates Choroidal Neovascularization by Suppressing Inflammation and Metabolic Reprogramming.

Authors:  Ji Yeon Do; Juhee Kim; Mi-Jin Kim; Jung Yi Lee; So-Young Park; Ryoji Yanai; In-Kyu Lee; Sungmi Park; Dong Ho Park
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-10-01       Impact factor: 4.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.